Identification of α-1L adrenoceptor in rabbit ear artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 3, 2004, Pages 995-1002

  Hiraizumi Hiraoka, Yasuko ^a   Tanaka, Takashi ^a   Yamamoto, Hatsumi ^a   Suzuki, Fumiko ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' (2 AMINO 1 HYDROXYETHYL) 4' FLUOROMETHANESULFONANILIDE; 5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; NORADRENALIN; PRAZOSIN; RECEPTOR SUBTYPE; SILODOSIN; TAMSULOSIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG COMPETITION; DRUG SELECTIVITY; EAR ARTERY; LIGAND BINDING; MALE; MICROSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RABBIT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARTERIES; CELL MEMBRANE; EAR; INDOLES; MALE; PRAZOSIN; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-1; TRITIUM;

EID: 4243084362     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.066985     Document Type: Article

References (38)

1. Amobi NIM, Guillebaud J, Kaisary AV, Turner E, and Smith ICH (2002) Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens. Br J Pharmacol 136:127-135.
2. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Bylund DB and Toews ML (1993) Radioligand binding methods: practical guide and tips. Am J Physiol 265:L421-L429.
5. Colucci WS, Gimbrone MA Jr, and Alexander RW (1981) Regulation of the postsynaptic alpha-adrenergic receptor in rat mesenteric artery: effects of chemical sympathectomy and epinephrine treatment. Circ Res 48:104-111.
6. Faber JE, Yang N, and Xin XH (2001) Expression of alpha-adrenoceptor subtypes by smooth muscle cell and adventitial fibroblast in rat aorta and in cell culture. J Pharmacol Exp Ther 298:441-452.
7. Fagura MS, Lydford SJ, and Dougall IG (1997) Pharmacological classification of alpha-1 adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br J Pharmacol 120:247-258.
8. Ford AP, Arredondo NF, Blue DR Jr, Bonhaus DW, Jasper J, Kava MS, Lesnick J, Pfister JR, Shieh IA, Vimont RL, et al. (1996) RS-17053 (N-[2-(2- cyclopropylmethoxyphenoxy)ethyl])-5-chloro-alpha, alpha-dimethyl-1H-indole-3- ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49:209-215.
9. Ford APDW, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, and Clarke DE (1997) Pharmacological pleiotropism of the human recombinant alpha-1A adrenoceptor. Br J Pharmacol 121:1127-1135.
10. Furchgott RF (1972) The classification on adrenoceptors (adrenergic receptors): an evaluation from the standpoint of receptor theory, in Handbuch der Experimentellen pharmacology (Blaschko H and Muscholl E eds) vol 3, pp 283-335 Springer, New York.
11. Goetz AS, King HK, Ward SDC, True TA, Rimele TJ, and Saussy DL Jr (1995) BMY 7378 is a selective antagonist of the D subtype of alpha-1 adrenoceptors. Eur J Pharmacol 272:R5-R6.
12. Hancock AA (1995) Alpha1 adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology. Drug Dev Res 39:54-107.
13. Hieble JP (2000) Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. Pharm Acta Helv 74:163-171.
14. Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, and Ruffolo RR Jr (1995) International Union of Pharmacology. X. Recommendation for nomenclature of alpha-1 adrenoceptors: consensus update. Pharmacol Rev 47:267-270.
15. Hiraoka Y, Ohmura T, Oshita M, Oshita M, Watanabe Y, Morikawa K, Nagata O, Kato H, Taniguchi T, and Muramatsu I (1999) Binding and functional characterization of alpha-1 adrenoceptor subtypes in the rat prostate. Eur J Pharmacol 366:119-126.
16. 1-adrenoceptor subtypes in the rabbit prostate. J Auton Pharmacol 15:271-278.
17. Honner V and Docherty JR (1999) Investigation of the subtypes of alpha-1 adrenoceptor mediating contractions of rat vas deferens. Br J Pharmacol 128:1323-1331.
18. Kenny B, Ballard S, Blagg J, and Fox D (1997) Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem 40:1293-1315.
19. Lachnit WG, Tran AM, Clarke DE, and Ford APDW (1997) Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 120:819-826.
20. Mackenzie JF, Daly CJ, Pediani JD, and McGrath JC (2000) Quantitative imaging in live human cells reveals intracellular alpha-1 adrenoceptor ligand-binding sites. J Pharmacol Exp Ther 294:434-443.
21. 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 352:1-10.
22. Michelotti GA, Price DT, and Schwinn DA (2000) Alpha-1 adrenoceptor regulation: basic science and clinical implications. Pharmacolol Ther 88:281-309.
23. Muramatsu I, Murata S, Isaka M, Piao HL, Zhu J, Suzuki F, Miyamoto S, Oshita M, Watanabe Y, and Taniguchi T (1998a) Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sci 62:1461-1465.
24. Muramatsu I, Ohmura T, Hashimoto S, and Oshita M (1995a) Functional subclassification of vascular alpha1 adrenoceptors. Pharmacol Commun 6:23-28.
25. Muramatsu I, Ohmura T, and Kigoshi S (1995b) Pharmacological profiles of a novel alpha-1 adrenoceptor agonist, PNO-49B, at alpha-1 adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 351:2-9.
26. Muramatsu I, Oshita M, Ohmura T, Kigoshi S, Akino H, Gobara M, and Okada K (1994) Pharmacological characterization of alpha-1 adrenoceptor subtypes in the human prostate: functional and binding studies. Br J Urol 74:572-578.
27. Muramatsu I, Taniguchi T, and Okada K (1998b) Tamsulosin: alpha-1 adrenoceptor subtype-selectivity and comparison with terazosin. Jpn J Pharmacol 78:331-335.
28. Murata S, Taniguchi T, and Muramatsu I (1999) Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213 and its suitability as a tritiated radioligand. Br J Pharmacol 127:19-26.
29. 1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol 127:1367-1374.
30. Ohmura T, Oshita M, Kigosh S, and Muramatsu I (1992) Identification of alpha-1 adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br J Pharmacol 107:697-704.
31. 1-adrenoceptor subtypes in rabbit thoracic aorta. Br J Pharmacol 108:1071-1076.
32. Suzuki F, Taniguchi T, Nakamura S, Akagi Y, Kubota T, Satoh M, and Muramatsu I (2002) Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol 135:600-608.
33. Taki N, Tanaka T, Zhang L, Suzuki F, Israilova M, Taniguchi T, Hiraizumi-Hiraoka Y, Shinozuka K, Kunitomo M, and Muramatsu I (2004) Alpha-1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery. Br J Pharmacol 142:647-656.
34. Tanaka T, Zhang L, Suzuki F, and Muramatsu I (2004) Alpha-1 adrenoceptors: evaluation of receptor subtype binding-kinetics in intact arterial tissues and comparison with membrane binding. Br J Pharmacol 141:468-476.
35. Testa R, Guarneri L, Angelico P, Poggesi E, Taddei C, Sironi G, Colombo D, Sulpizio AC, Naselsky DP, Hieble JP, et al. (1997) Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739(SB 216469): II. Role of the alpha-1L adrenoceptor in tissue selectivity. J Pharmacol Exp Ther 281:1284-1293.
36. Williams TJ, Clarke DE, and Ford APDW (1996) Whole-cell radioligand-binding assay reveals alpha-1A adrenoceptor (AR) antagonist profile for the human cloned alpha-1L AR in chinese hamster ovary (CHO-K1) cells. Br J Pharmacol 119:359P.
37. Yang M, Verfurth F, Buscher R, and Michel MC (1997) Is alpha-1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedebergs Arch Pharmacol 335: 438-446.
38. Zhong H and Minneman KP (1999) Alpha-1 adrenoceptor subtypes. Eur J Pharmacol 37:261-276.